Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Who May Be Eligible (Plain English)

Who May Qualify: - Isolated CDH with liver up - Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery - Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days - Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surgery - Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category - Maternal age greater than or equal to 18 years - Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category - Normal karyotype or FISH - Normal fetal echocardiogram - Singleton pregnancy - Willing to remain in the greater Cincinnati area for remainder of pregnancy - Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days - Family meets psychosocial criteria Who Should NOT Join This Trial: - Patient \< 18 years old - Multi-fetal pregnancy - Rubber latex allergy - Preterm labor, cervix shortened (\<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa - Bilateral CDH, isolated left sided CDH with an O/E \> 30% - Additional fetal anomaly by ultrasound, MRI, or echocardiogram - Chromosomal abnormalities - Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy - Incompetent cervix with or without a cerclage - Placental abnormalities known at time of enrollment - Maternal HIV, Hepatits B, Hepatitis C - Maternal uterine anomaly - No safe or technically feasible fetoscopic approach to balloon placement - Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Isolated CDH with liver up * Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery * Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days * Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surgery * Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category * Maternal age greater than or equal to 18 years * Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category * Normal karyotype or FISH * Normal fetal echocardiogram * Singleton pregnancy * Willing to remain in the greater Cincinnati area for remainder of pregnancy * Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days * Family meets psychosocial criteria Exclusion Criteria: * Patient \< 18 years old * Multi-fetal pregnancy * Rubber latex allergy * Preterm labor, cervix shortened (\<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa * Bilateral CDH, isolated left sided CDH with an O/E \> 30% * Additional fetal anomaly by ultrasound, MRI, or echocardiogram * Chromosomal abnormalities * Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy * Incompetent cervix with or without a cerclage * Placental abnormalities known at time of enrollment * Maternal HIV, Hepatits B, Hepatitis C * Maternal uterine anomaly * No safe or technically feasible fetoscopic approach to balloon placement * Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy

Treatments Being Tested

DEVICE

Fetal Tracheal Occlusion

Fetuses with congenital diaphragmatic hernia with an observed to expected lung-to-head ratio of \<25%, LHR \<1, o/e LHR\<30% (moderate), singleton pregnancy, no known other anomalies, gestational age \< 29 weeks 6 days, no maternal disease, maternal age \> 18 years old meet criteria to be offered tracheal occlusion. We want to test feasibility and efficacy in our center.

Locations (1)

Cincinnati Children's Hospital Medical Center (CCHMC)
Cincinnati, Ohio, United States